Evaxion Biotech (EVAX) Misses Q3 EPS by 4c

Evaxion Biotech (NASDAQ: EVAX) reported Q3 EPS of ($0.04). Revenue for the quarter came in at $3.01 million.

For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.

You May Also Be Interested In

• JPMorgan Upgrades Diploma Plc. (DPLM:LN) to Overweight
• ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
• Softbank Group Plans ¥1 Trillion Retail Bond Sale - Bloomberg